Israel Chemicals (ICL) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Israel Chemicals (NYSE:ICL) posted its quarterly earnings data on Wednesday. The basic materials company reported $0.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.08 by $0.03, Morningstar.com reports. The firm had revenue of $1.36 billion for the quarter. Israel Chemicals had a net margin of 4.47% and a return on equity of 13.20%. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.09 EPS.

Israel Chemicals (ICL) traded up $0.19 during mid-day trading on Wednesday, hitting $4.15. 214,241 shares of the company traded hands, compared to its average volume of 369,209. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.70 and a current ratio of 1.24. Israel Chemicals has a 52 week low of $3.85 and a 52 week high of $4.95. The company has a market cap of $5,049.86, a price-to-earnings ratio of 21.74 and a beta of 1.16.

ICL has been the topic of several research reports. ValuEngine upgraded shares of Israel Chemicals from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Zacks Investment Research raised shares of Israel Chemicals from a “sell” rating to a “hold” rating in a report on Thursday, February 1st. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Israel Chemicals presently has a consensus rating of “Hold” and an average target price of $4.88.

Several hedge funds have recently added to or reduced their stakes in the stock. Stevens Capital Management LP bought a new stake in Israel Chemicals in the 3rd quarter worth $105,000. Amundi Pioneer Asset Management Inc. bought a new stake in Israel Chemicals in the 4th quarter worth $171,000. Geode Capital Management LLC bought a new stake in Israel Chemicals in the 4th quarter worth $182,000. Citadel Advisors LLC bought a new stake in Israel Chemicals in the 3rd quarter worth $214,000. Finally, Russell Investments Group Ltd. grew its holdings in Israel Chemicals by 117.2% in the 3rd quarter. Russell Investments Group Ltd. now owns 88,128 shares of the basic materials company’s stock worth $390,000 after acquiring an additional 47,562 shares during the last quarter. 6.31% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Israel Chemicals (ICL) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/israel-chemicals-icl-posts-quarterly-earnings-results-beats-expectations-by-0-03-eps.html.

Israel Chemicals Company Profile

Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash and salt from subterranean mines in Spain and the United Kingdom, as well as uses part of the potash to produce compound fertilizers; mines and processes phosphate rock in open mines; and produces sulfuric acid, agricultural phosphoric acid, phosphate fertilizers, compound fertilizers, liquid fertilizers, and soluble fertilizers.

Earnings History for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply